New horizons for the infectious diseases specialist: How gut microflora promote health and disease

Current Infectious Disease Reports

Volumn 10, Issue 2, 2008, Pages 92-98

  Rabizadeh, Shervin ^b   Sears, Cynthia ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYCLOOXYGENASE 2; GENE PRODUCT; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN RECEPTOR; PROBIOTIC AGENT; PROTEIN ATG16L1; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BACTERIAL METABOLISM; BACTERIAL TRANSLOCATION; COLON CANCER; COMMENSALISM; CROHN DISEASE; ENTERITIS; GRAFT VERSUS HOST REACTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INTESTINE ABSORPTION; INTESTINE FLORA; IRRITABLE COLON; NONHUMAN; OBESITY; PATHOGENICITY; PROTEIN EXPRESSION; REVIEW; SYMBIOSIS;

EID: 56349122532     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-008-0017-8     Document Type: Review

References (50)

1. Falk PG, Hooper LV, Midtvedt T, Gordon JI: Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998, 62:1157-1170.
2. Palmer C, Bik EM, Digiulio DB, et al.: Development of the human infant intestinal microbiota. PLoS Biol 2007, 5:e177.
3. Hooper LV, Gordon JI: Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118.
4. Eckburg PB, Bik EM, Bernstein CN, et al.: Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
5. Guarner F: Enteric flora in health and disease. Digestion 2006, 73(Suppl 1):5-12.
6. Hooper LV, Wong MH, Thelin A, et al.: Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884.
7. Xu J, Bjursell MK, Himrod J, et al.: A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003, 299:2074-2076.
8. Macpherson AJ, Uhr T: Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665.
9. Gill SR, Pop M, Deboy RT, et al.: Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
10. Backhed F, Ley RE, Sonnenburg JL, et al.: Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
11. Sonnenburg JL, Xu J, Leip DD, et al.: Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005, 307:1955-1959.
12. Huycke MM, Gaskins HR: Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 2004, 229:586-597.
13. Wang X, Huycke MM: Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterol 2007, 132:551-561.
14. Stappenbeck TS, Hooper LV, Gordon JI: Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002, 99:15451-15455.
15. Macpherson AJ, Uhr T: Compartmentalization of the mucosal immune responses to commensal intestinal bacteria. Ann N Y Acad Sci 2004, 1029:36-43.
16. MacDonald TT, Monteleone G: Immunity, inflammation, and allergy in the gut. Science 2005, 307:1920-1925.
17. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL: An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
18. Duquesne S, Petit V, Peduzzi J, Rebuffat S: Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria. J Mol Microbiol Biotechnol 2007, 13:200-209.
19. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al.: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
20. Eckmann L: Defence molecules in intestinal innate immunity against bacterial infections. Curr Opin Gastroenterol 2005, 21:147-151.
21. Cash HL, Whitham CV, Behrendt CL, Hooper LV: Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
22. Neish AS, Gewirtz AT, Zeng H, et al.: Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000, 289:1560-1563.
23. Sartor RB: Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006, 3:390-407.
24. Eckburg PB, Relman DA: The role of microbes in Crohn's disease. Clin Infect Dis 2007, 44:256-262.
25. Cho JH, Weaver CT: The genetics of inflammatory bowel disease. Gastroenterol 2007, 133:1327-1339.
26. Duerr RH, Taylor KD, Brant SR, et al.: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
27. Garrett WS, Lord GM, Punit S, et al.: Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007, 131:33-45.
28. Swidsinski A, Weber J, Loening-Baucke V, et al.: Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005, 43:3380-3389.
29. Lodes MJ, Cong Y, Elson CO, et al.: Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004, 113:1296-1306.
30. Backhed F, Ding H, Wang T, et al.: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004, 101:15718-15723.
31. Ley RE, Backhed F, Turnbaugh P, et al.: Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005, 102:11070-11075.
32. Turnbaugh PJ, Ley RE, Mahowald MA, et al.: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
33. Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
34. Cooke KR, Gerbitz A, Crawford JM, et al.: LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 2001, 107:1581-1589.
35. Brenchley JM, Price DA, Schacker TW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371.
36. Barbara G, Stanghellini V, Brandi G, et al.: Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005, 100:2560-2568.
37. Lee HR, Pimentel M: Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth. Curr Gastroenterol Rep 2006, 8:305-311.
38. Marshall JK, Thabane M, Garg AX, et al.: Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterol 2006, 131:445-450.
39. Jiang ZD, DuPont HL, Garey K, et al.: A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol 2006, 101:1112-1116.
40. Jiang ZD, Garey KW, Price M, et al.: Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Clin Gastroenterol Hepatol 2007, 5:964-968.
41. Nougayrede JP, Homburg S, Taieb F, et al.: Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006, 313:848-851.
42. Arber N, Eagle CJ, Spicak J, et al.: Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006, 355:885-895.
43. Toprak NU, Yagci A, Gulluoglu BM, et al.: A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006, 12:782-786.
44. Sears C, Franco A, Wu S: Bacteroides fragilis toxins. In The Comprehensive Sourcebook of Bacterial Protein Toxins. Edited by Alouf J, Popoff M. Oxford, England: Academic Press, 2006:535-546.
45. Probiotics. Med Lett Drugs Ther 2007, 49:66-68.
46. Deshpande G, Rao S, Patole S: Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007, 369:1614-1620.
47. Ewaschuk J, Endersby R, Thiel D, et al.: Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 2007, 46:841-850.
48. Tao Y, Drabik KA, Waypa TS, et al.: Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 2006, 290:C1018-C1030.
49. Flanagan JL, Brodie EL, Weng L, et al.: Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 2007, 45:1954-1962.
50. Turnbaugh PJ, Ley RE, Hamady M, et al.: The human microbiome project. Nature 2007, 449:804-810.